Fundz
Real-time · AI · Cross-signal

Shuttle Pharmaceutical Holdings just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Shuttle Pharmaceutical Holdings, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Shuttle Pharma Enters into Sponsored Research Agreement with UCSF to Advance PSMA Development Program

Dec 19, 2024•over 1 year ago

Contract Type

agreement

RockvilleBiotechnologyHealth CareMedicalPharmaceutical

Description

Shuttle Pharmaceuticals Holdings, Inc. announced a sponsored research agreement with the University of California, San Francisco (UCSF) to advance pre-clinical development of Shuttle Diagnostics, Inc.’s ligand to the prostate-specific membrane antigen (PSMA) as a potential diagnostic and therapeutic, or theranostic, molecule.

Company Information

Company

Shuttle Pharmaceutical Holdings

Location

Rockville, Maryland, United States

About

Shuttle owns a pharmaceutical software AI driven platform for molecular discovery and early-stage drug development. The Molecule.ai platform helps researchers explore the chemical space more efficiently. By combining modern AI techniques with structured workflows, the platform aids in drug development decisions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Shuttle Pharmaceutical Holdings's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months